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INTRODUCTION
Control of the hepatic blood flow has allowed major hepatectomies to be carried out with decreased blood loss but it has done so at the expense of liver damage from ischemicreperfusion (IR) injury. IR injury is initiated by reactive oxygen species which cause direct apoptotic and necrotic cell death of hepatocytes and sinusoidal endothelial cells (SEC) 1, 2 . A cascade of molecular mediators is activated leading to microvascular and acute inflammatory changes. Platelet plugging, reduced nitric oxide (NO), and vasoconstrictors lead to sinusoidal perfusion failure 1, 2 . Proinflammatory cytokines produced by Kupffer cells result in T-cell and neutrophil activation and transmigration, resulting in more necrosis and/or apoptosis of SEC and hepatocytes 1, 2 .
IR injury results in elevated liver enzymes and increased postoperative morbidity [2] [3] [4] [5] [6] . Patients with cirrhotic or steatotic liver are more sensitive to IR injury than patients with normal liver 3, 6 . Many interventions have been used to decrease IR injury 3, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and previous standard pairwise meta-analyses comparing these interventions [23] [24] [25] were limited by the fact that indirect comparisons between interventions could not be performed. The aim of this network metaanalysis is to combine direct and indirect evidence across trials in order to compare perioperative outcomes of different interventions aimed at decreasing IR injury during elective hepatectomy.
METHODS

Search strategy
A comprehensive literature search was performed of the following databases: MEDLINE, EMBASE, Science Citation Index Expanded, Cochrane Central Register of Controlled Trials (CENTRAL). Detailed search strategy is provided in Supplementary Table 1 . No restrictions were made based on language, publication year, or publication status. Only randomized controlled trials (RCTs) were considered for inclusion.
Outcomes of interest
Primary outcomes 
Data collection
The following data were independently extracted by two review authors from each study: first author, year of publication, country, inclusion and exclusion criteria, participant characteristics, number of participants with liver cirrhosis or liver steatosis, major or minor liver resections performed, study design, and outcomes of interest described above. The risk of bias of the included trials was assessed based on the following bias risk domains: allocation sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete outcome data, selective outcome reporting, and vested interest bias. For each of these risk domains of bias the studies were categorized as low risk, uncertain risk, and high risk of bias.
Statistical analysis
For binary outcomes the odds ratio (OR) was calculated, and for continuous outcomes the mean difference (MD) was calculated. For each outcome of interest, Stata/IC 11 (StataCorp LP) was used to draw a network plot of all the interventions assessed for that specific outcome. Any interventions that were not connected to the other interventions through the network plot were excluded from the analysis of that outcome. A Bayesian network meta-analysis was conducted using the Markov chain Monte Carlo method in WinBUGS 1.4. The treatment contrast (OR for binary outcomes, MD for continuous outcomes) for any two interventions was modelled as a function of comparisons between each individual intervention and an arbitrarily selected reference group 28 . The reference group was selected to be the surgery alone group.
The residual deviance and Deviance Information Criteria (DIC) were used for assessing between study heterogeneity as per the guidance from the National Institute for Health and Clinical Excellence (NICE) Decision Support Unit (DSU) documents 29 . Three different models were run for each outcome: fixed-effect model, random-effects model, and random-effects inconsistency model. The choice of the model was based on the model fit, and a lower DIC indicated a better model fit 29 . Evidence of inconsistency between direct and indirect comparisons was assessed by examining the geometry of the network diagrams and by comparing the deviance and DIC statistics of the consistency and inconsistency models 30 . The probability of ranking of an intervention for each outcome of interest was calculated.
RESULTS
Eligible studies
A total of 522 references were identified through electronic searches of CENTRAL (n=60), MEDLINE (n=154), EMBASE (n=119), and Science Citation Index Expanded (n=189). Five more references were identified for further assessment through scanning reference lists. The study flow diagram is shown in Figure 1 . After reviewing 75 full-text articles, 31 references were excluded. Forty four RCTs met the inclusion criteria 3, 7-21, 31-58 reporting on 2457
participants. The characteristics of the included trials are shown in Table 1 . The risk of bias of the trials is shown in Supplementary Figure 1 .
Overall network meta-analysis
An overall network meta-analysis was performed to compare eight classes of active interventions aimed at decreasing IR injury along with a control group which was surgery alone. The classes of intervention were grouped based on their mechanism of action:
hypothermia, ischemic preconditioning, antioxidants, immunomodulators, cardiovascular modulators, steroids, treatments that increase hepatic glycogen, and miscellaneous therapies (Table 2 ). Statistically significant results are shown in Table 3 . The classes of interventions with the highest probability of ranking from best to worst for the outcomes of interest are summarized in Table 4 .
Mortality
The fixed-effect model was preferred for this outcome based on the DIC statistics, and there was no evidence of inconsistency in the networks. The pairwise odds ratios of the different treatment comparisons identified no significant difference in mortality between the different groups. The network plot for mortality is shown in Figure 2 .
Serious adverse events
The fixed-effect model was used and there was no evidence of inconsistency. Significantly fewer serious adverse events were found in the ischemic preconditioning and cardiovascular modulators groups compared to surgery alone. There were significantly fewer serious adverse events in the miscellaneous group compared to surgery alone, ischemic preconditioning, immunomodulators, and steroids. There was no significant difference in the other comparisons.
Proportion of patients transfused
The fixed-effect model was preferred and there was no evidence of inconsistency. Pairwise comparison of the interventions showed that significantly fewer people were transfused with ischemic preconditioning compared to steroids. There was no significant difference in the other comparisons.
Quantity of blood transfusion per patient
The random-effects model was used and there was no evidence of inconsistency. No evidence of any significant difference in quantity of blood transfusion per patient between the different interventions was found.
Operative blood loss
The fixed-effect model was used and there was no evidence of inconsistency. The pairwise mean differences of the different group comparisons showed that ischemic preconditioning had significantly lower operative blood loss compared to all other groups and ranked best treatment with 99.7% probability. The surgery alone group had significantly lower operative blood loss compared to all other groups except ischemic preconditioning. The steroids and increased hepatic glycogen groups were found to have significantly lower operative blood loss compared to the hypothermia, immunomodulators, and miscellaneous groups.
Length of hospital stay
The random-effects model was preferred and there was no evidence of inconsistency. The pairwise comparison of the interventions showed ischemic preconditioning to have significantly shorter length of hospital stay compared to surgery alone by 2.3 days. There was no significant difference in the other comparisons.
ITU stay
The random-effects model was preferred and there was no evidence of inconsistency. Pairwise comparison of the groups showed no evidence of any significant difference in the ITU stay.
Operative time
The fixed-effect model was used and there was no evidence of inconsistency. The pairwise mean differences of the different treatments showed ischemic preconditioning and increased hepatic glycogen to have significantly shorter operative time compared to steroids by 17 and 26 minutes respectively. There was no significant difference in the operating time between the other comparisons.
Sensitivity network meta-analysis -individual interventions
A sensitivity network meta-analysis was performed to compare all the individual interventions included in each class of interventions aimed at decreasing IR injury. No significant difference was found in mortality, quantity of blood transfusion per patient, and ITU stay, between the different interventions. Ischemic preconditioning, sevoflurane, verapamil, and gabexate mesilate had significantly fewer serious adverse events compared to surgery alone. Fewer people were transfused with ischemic preconditioning compared to steroids.
Ischemic preconditioning was found to have significantly lower operative blood loss compared to surgery alone. Ischemic preconditioning and surgery alone had lower operative blood loss compared to hypothermia, prostaglandin E1, steroids, verapamil, S-adenosyl-L-methionine, insulin, branched chain aminoacids, gabexate mesilate, and melatonin. Ischemic preconditioning was found to have significantly shorter length of hospital stay compared to surgery alone. Furthermore, ischemic preconditioning and pre-storing hepatocellular glycogen were found to have significantly shorter operative time compared to steroids.
Sensitivity network meta-analysis -larger groups
A network meta-analysis was performed to compare the following 4 larger groups: surgery alone, hypothermia, ischemic preconditioning, and all pharmacological interventions. There was no significant difference in mortality, proportion of patients transfused, quantity of blood transfusion per patient, ITU stay, and operative time, between the 4 groups. Ischemic preconditioning and pharmacological interventions were found to have significantly fewer serious adverse events compared to surgery alone.
Ischemic preconditioning had a high probability (87%) of being the best treatment for operating time. Ischemic preconditioning had significantly lower operative blood loss compared to surgery alone, hypothermia, and pharmacological interventions, and was confirmed best treatment for operative blood loss with 100% probability. Surgery alone had significantly lower operative blood loss compared to hypothermia and pharmacological interventions. Moreover, ischemic preconditioning and pharmacological interventions resulted in significantly shorter hospital stay compared to surgery alone.
Metaregression -cirrhotic livers
A metaregression was performed based on the percentage of cirrhotic livers included in each trial. No significant difference was identified between the classes of interventions with regards to mortality, proportion of patients transfused, quantity of blood transfused per patient, operating time, hospital stay, and ITU stay. The ischemic preconditioning, antioxidants, and miscellaneous groups had significantly fewer serious adverse events compared to the surgery alone group. The surgery alone, ischemic preconditioning, steroids, and increased hepatic glycogen groups resulted in significantly lower operative blood loss compared to the immunomodulators and miscellaneous groups of interventions. In addition, ischemic preconditioning had significantly lower operative blood loss compared to surgery alone.
Metaregression -major liver resections
A metaregression was performed based on the percentage of major liver resections performed in each trial. 
DISCUSSION
This network meta-analysis identified three groups of interventions -ischemic preconditioning, cardiovascular modulators, miscellaneous group -which resulted in fewer serious adverse events compared to the surgery alone group. Although there was a high probability that the miscellaneous group of interventions was best for reducing serious adverse events (74% chance), sensitivity analysis performed showed none of the individual interventions within the miscellaneous group to have high probability of being the best treatment for this outcome. Overall, no individual intervention had a probability higher than 40% of being best treatment for serious adverse events. Although sevoflurane, verapamil, and gabexate mesilate were found to have fewer serious adverse events during sensitivity analysis, none of these treatments significantly reduced ITU or hospital stay, which would be anticipated if an intervention made a significant reduction in serious adverse events. On the other hand, ischemic preconditioning, which resulted in fewer serious adverse events, showed multiple additional clinical benefits including shorter hospital stay, shorter operative time, and decreased blood loss.
The decreased operative time is perhaps counter-intuitive as ischemic preconditioning is an additional operative manoeuver. However, ischemic preconditioning may decrease operative time by decreasing the time taken for parenchymal transection because of reduced blood loss during surgery, facilitating subsequent operative manoeuvers such as parenchymal dissection, and by shortening the time necessary for hemostasis 35, 60 . Blood loss is one of the most important factors affecting the peri-operative outcomes of patients undergoing liver resection [61] [62] [63] . This study showed that ischemic preconditioning had significantly lower operative blood loss compared to the surgery alone group and compared to all other interventions, and it had a high probability of being the best treatment for this outcome.
Another important finding was that the surgery alone group had significantly lower operative blood loss compared to all other interventions, except the ischemic preconditioning group.
Therefore, not only was ischemic preconditioning the only intervention to significantly reduce blood loss, but also all other interventions resulted in significantly higher operative blood loss compared to the surgery alone group. A possible explanation in the increase in operative blood loss by the other interventions is that by increasing the microvascular flow and perfusion of the liver in order to decrease IR injury, they result in increased overall blood flow and blood loss during hepatectomy. This apparent disadvantage in increasing blood loss of all other interventions except ischemic preconditioning should be weighed against any apparent benefit of these interventions, e.g. in reducing serious adverse events.
Trials in the literature demonstrated the beneficial effects of ischemic preconditioning on liver resection surgery in patients with background healthy livers, as well as those with background cirrhotic or steatotic livers, by showing a decrease in postoperative liver enzymes which are markers for liver parenchymal injury 3, 12, 13, 43, 64 . Although liver parenchymal injury is associated with derangements in the liver function tests (LFTs), this network meta-analysis did not assess LFTs due to significant variation between the included trials in the way LFTs were assessed. In particular, LFTs were reported at different time intervals, different methods of measurement were used between trials, and different measurement scales were reported.
Perioperative outcomes, including adverse events, are thought to be clinically more relevant and were compared in this study.
In all the trials included in this review where ischemic preconditioning was used to decrease IR injury, ischemic preconditioning was performed with liver vascular inflow occlusion (Pringle manoeuver). Nevertheless, there was variability between trials in the timing of ischemic preconditioning and the type of vascular occlusion performed during liver resection.
In some trials, ischemic preconditioning was performed with 10 minutes of vascular inflow occlusion and 10 minutes of reperfusion 3, 12, 13, 49, 53 , whereas in other trials ischemic preconditioning was performed with 5 minutes of vascular inflow occlusion and 5 minutes of reperfusion 36, 43, 44 . Furthermore, in some trials ischemic preconditioning was followed by vascular inflow occlusion 12, 13, 35, 46, 49 , whereas in other trials it was followed by selective hepatic vascular exclusion 8, 9, 53 . The downside of this is that it does not allow for the optimal ischemic preconditioning protocol to be determined accurately, or even whether some protocols were ineffective.
Other possible sources of bias in this network meta-analysis are the proportion of cirrhotic and steatotic livers included in each trial, and the proportion of patients undergoing major liver resections. Therefore, metaregressions were performed based on the proportion of cirrhotic livers included and the proportion of major liver resections performed in each trial.
Unfortunately, due to the low number of trials (7 trials 
